Welcome the Future!
Final packaging may vary. All of the following products are in different development stages. Kindly read the footnote.
Estronova
in development
Estradiol Hemihydrate 2 mg
Renovopenem
in development
Meropenem 1 gm/vial
Sergometrine
in development
Methylergometrine 0.15 mg/ml
Renotolamine
in development
Phentolamine Mesylate 10 mg/ml
Renovotocin
in development
Oxytocin 10 I.U/ml
Renovo D3 Drops
in development
In-Active Cholecalciferol 4000 I.U/ml
Renoadd
in development
Spray
The information contained on this page is accurate as of May 8, 2023 to the best of Renovo Egypt’s knowledge. As some products are still confidential, some of them may not be identified in this list. Renovo Egypt is including new indications or enhancements which target unmet medical need or represent significant commercial opportunities. The order of the products on this page does not necessarily mean the order of the launch of these products in the markets.
